Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Stone

Showing results (111-120 of 420) with videos related to

Pageof 42
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2024
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AMLEunice S Wang, Aaron D Goldberg, Martin Tallman, et al.
Blood|June 7, 2019
Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignanciesMichael A Liu, Clark DuMontier, Anays Murillo, et al.
Haematologica|July 30, 2016
Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)Christian Niederwieser, Deedra Nicolet, Andrew J Carroll, et al.
Haematologica|December 1, 2022
Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysisShai Shimony, Alon Rozental, Jan P Bewersdorf, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2008
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804Richard M Stone, Kathleen A Donohue, Wendy Stock, et al.
Journal of Geriatric Oncology|June 16, 2015
Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adultsK Rebecca Fega, Gregory A Abel, Gabriela Motyckova, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Association of Polypharmacy and Potentially Inappropriate Medications With Frailty Among Older Adults With Blood CancersTammy T Hshieh, Clark DuMontier, Timothy Jaung, et al.
Molecular Cancer Therapeutics|October 17, 2013
Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cellsHelena Mistry, Grace Hsieh, Sara J Buhrlage, et al.
Blood|April 21, 2009
Identification of AML1-ETO modulators by chemical genomicsSteven M Corsello, Giovanni Roti, Kenneth N Ross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based reviewDenise M Oliansky, Frederick Appelbaum, Peter A Cassileth, et al.
Pageof 42

Showing results (111-120 of 420) with videos related to

Sort By:
Pageof 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2024
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AMLEunice S Wang, Aaron D Goldberg, Martin Tallman, et al.
Blood|June 7, 2019
Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignanciesMichael A Liu, Clark DuMontier, Anays Murillo, et al.
Haematologica|July 30, 2016
Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance)Christian Niederwieser, Deedra Nicolet, Andrew J Carroll, et al.
Haematologica|December 1, 2022
Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysisShai Shimony, Alon Rozental, Jan P Bewersdorf, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2008
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804Richard M Stone, Kathleen A Donohue, Wendy Stock, et al.
Journal of Geriatric Oncology|June 16, 2015
Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adultsK Rebecca Fega, Gregory A Abel, Gabriela Motyckova, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Association of Polypharmacy and Potentially Inappropriate Medications With Frailty Among Older Adults With Blood CancersTammy T Hshieh, Clark DuMontier, Timothy Jaung, et al.
Molecular Cancer Therapeutics|October 17, 2013
Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cellsHelena Mistry, Grace Hsieh, Sara J Buhrlage, et al.
Blood|April 21, 2009
Identification of AML1-ETO modulators by chemical genomicsSteven M Corsello, Giovanni Roti, Kenneth N Ross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based reviewDenise M Oliansky, Frederick Appelbaum, Peter A Cassileth, et al.
Pageof 42